A number of manufacturers of OTC internal analgesic drug products already have voluntarily implemented labeling changes to identify these potential safety concerns,the FDA said in an official statement.
A number of manufacturers of OTC internal analgesic drug products already have voluntarily implemented labeling changes to identify these potential safety concerns,the FDA said in an official statement.
联邦卫生局今天宣布要加强普通OTC止痛药物，如扑热息痛，阿司匹林，布洛芬的警告标记。这是FDA的最新举措，以警告数百万的美国人这类药物带来的潜在的严重健康威胁。